Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease.
about
Safety of weekly adalimumab in the treatment of juvenile idiopathic arthritis and pediatric chronic uveitis.Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease.Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis.
P2860
Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Efficacy and Safety of Escalat ...... Patients with Crohn's Disease.
@ast
Efficacy and Safety of Escalat ...... Patients with Crohn's Disease.
@en
type
label
Efficacy and Safety of Escalat ...... Patients with Crohn's Disease.
@ast
Efficacy and Safety of Escalat ...... Patients with Crohn's Disease.
@en
prefLabel
Efficacy and Safety of Escalat ...... Patients with Crohn's Disease.
@ast
Efficacy and Safety of Escalat ...... Patients with Crohn's Disease.
@en
P2093
P2860
P1476
Efficacy and Safety of Escalat ...... Patients with Crohn's Disease.
@en
P2093
Andreas Lazar
Bidan Huang
Frank Ruemmele
Jeffrey S Hyams
Marla C Dubinsky
Nael M Mostafa
Roopal B Thakkar
Samantha Eichner
William A Faubion
P2860
P304
P356
10.1097/MIB.0000000000000715
P577
2016-03-04T00:00:00Z